Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse used as an adjunct to non-surgical periodontal treatment:: A double-blind clinical study

被引:76
|
作者
Gurgan, Cem A. [1 ]
Zaim, Eylem [1 ]
Bakirsoy, Isil [1 ]
Soykan, Emel [1 ]
机构
[1] Ankara Univ, Fac Dent, Dept Periodontol, TR-06500 Ankara, Turkey
关键词
chlorhexidine; side effects;
D O I
10.1902/jop.2006.050141
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: The aims of this clinical study were to evaluate the short-term subjective (by means of questionnaire) and objective (by means of clinical examination) side effects of 0.2% chlorhexidine (CHX) mouthrinse without alcohol used as an adjunct to non-surgical periodontal treatment and to elucidate the relationship between the subjective and objective evaluations. Methods: This was a randomized, double-blind, placebo-controlled clinical trial with two groups: 1) the test group, rinsing with the test product (0.2% CHX without alcohol) twice per day for I week, and 2) the control (placebo) group, rinsing with a placebo solution twice per day for 1 week. Following the start of rinsing, patients were subjectively and objectively evaluated for the presence and severity of side effects (pain, burning sensation, pruritus, dryness of mouth, taste disturbance, mucosal irritations, and discoloration of tooth and tongue surfaces) at days 1, 3, and 7 of the rinsing period. The presence of subjective and objective side effects of the groups was compared via use of chi(2) and Fisher exact tests. Analysis of the subjective and objective side effects within the evaluation periods was done by McNemar test. Spearman correlation analysis was used to assess the relationships between the subjective and objective side effects. Results: None of the patients in either group complained of dryness of the mouth. The most commonly reported side effect was the change in color of the labial and buccal mucosa, particularly of the gingiva, after day 3 of rinsing. There were significant (r = 0.308 to 0.835; P < 0.05) correlations between the discolorations of tongue and tooth surfaces reported by the patients and clinically detected at all evaluation periods. There was a significant and positive relationship between the subjective side effects and the soft tissue irritations when the duration of rinsing increased. Conclusion: Within the limits of this clinical evaluation, rinsing with 0.2% alcohol-free CHX for 1 week caused more irritation to oral mucosa, greater burning sensation, and increased altered taste perception compared to the placebo rinse.
引用
收藏
页码:370 / 384
页数:15
相关论文
共 45 条
  • [41] Primary Prevention of Adverse Gastroduodenal Effects from Short-Term Use of Non-Steroidal Anti-Inflammatory Drugs by Omeprazole 20 mg in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Study
    Jay C. Desai
    Shefali M. Sanyal
    Tyralee Goo
    Ariel A. Benson
    Carol A. Bodian
    Kenneth M. Miller
    Lawrence B. Cohen
    James Aisenberg
    Digestive Diseases and Sciences, 2008, 53 : 2059 - 2065
  • [42] Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: A randomized, double-blind, placebo-controlled study
    Desai, Jay C.
    Sanyal, Shefali M.
    Goo, Tyralee
    Benson, Ariel A.
    Bodian, Carol A.
    Miller, Kenneth M.
    Cohen, Lawrence B.
    Aisenberg, James
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (08) : 2059 - 2065
  • [43] Primary prevention by omeprazole 20 mg daily of the adverse gastrointestinal effects of short-term non-steroidal anti-inflammatory drug use in healthy subjects: A randomized, double-blind, placebo-controlled study
    Desai, Jay C.
    Sanyal, Shefali M.
    Goo, Tyralee
    Benson, Ariel A.
    Bodian, Carol A.
    Miller, Kenneth M.
    Cohen, Lawrence B.
    Aisenberg, James
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S170 - S170
  • [44] A Randomized, Double-Blind, Placebo-Controlled, Short-Term Monotherapy Study of MK-6186, an HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor, in Treatment-Naïve HIV-Infected Participants
    Schuermann, Dirk
    Hueser, Andreas
    Pfaefflin, Frieder
    Cilissen, Caroline
    De Lepeleire, Inge
    Larson, Patrick J.
    Anderson, Matt S.
    Rizk, Matthew L.
    Hofmann, Joerg
    Daeumer, Martin
    Stegemann, Miriam S.
    Stoch, Selwyn A.
    Wagner, Frank
    Iwamoto, Marian
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2025, 41 (01) : 11 - 19
  • [45] Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia - A Randomized, Double-Blind, Placebo-Controlled, Phase III Study -
    Yokote, Koutaro
    Niwa, Kiyoshi
    Hakoda, Tomomi
    Oh, Fumiki
    Kajimoto, Yoshitaka
    Fukui, Toshiki
    Kim, Hyosung
    Noda, Yoshinori
    Lundstrom, Torbjorn
    Yajima, Toshitaka
    CIRCULATION JOURNAL, 2020, 84 (06) : 994 - +